Leukapheresis Market Share

  • Report ID: 5887
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Leukapheresis Market Share

North American Market Forecast

North America industry is poised to account for largest revenue share of 36% by 2037. The primary drivers of the current leukapheresis industry are an increase in neurological illnesses and blood-related disorders like "leukemia," which are already extremely frequent and common in this region. Additionally, the region is home to highly qualified medical personnel and well-equipped facilities. Furthermore, the region sets the standard for the use of cell-based treatments including stem cells and CAR T-cell therapy. For instance, in December 2021, T-ChargeTM, Novartis's next-generation CAR-T platform, was unveiled. It will act as the basis for several novel investigational CAR-T cell therapies that the company has in the works. The leukapheresis market expanded as a result of the region's increasing need for cell-based therapies.

European Market Statistics

Leukapheresis market in Europe is expected to grow with a share of 28% by the end of 2037. The rising incidence of blood disorders is one of the key factors expanding the market in the region. Also, the growth can be attributed to the growing investment in the healthcare sector. For instance, 2018 saw USD 1.95 billion financed by Europe in research and innovation through 1.708 initiatives in 20 Member States. The top three countries with the largest financing shares are Spain, Hungary, and Poland. Furthermore, Europe is a center for immunotherapy, cancer, and hematology clinical research and innovation. Leading academic institutions and pharmaceutical businesses are present, which promotes innovation and expands the leukapheresis market.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5887
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lubricants is estimated at USD 226.13 million.

The leukapheresis market size was over USD 208.76 million in 2024 and is anticipated to cross USD 755.52 million by 2037, growing at more than 10.4% CAGR during the forecast period i.e., between 2025-2037. Growing demand for leukopaks in clinical research, growing cases of blood-related disorders, and increasing clinical trials for CAR T-cell Therapy will boost the market growth.

North America industry is poised to account for largest revenue share of 36% by 2037, due to increase in neurological illnesses and blood-related disorders like leukemia in the region.

The major players in the market are BioLineRx Ltd., Gilead Sciences, Inc., Haemonetics Corporation, Charles River Laboratories, Fresenius SE & Co., StemExpress, LLC, AllCells, LLC, Cerus Corporation, Hemacare Corporation, Macopharma SA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample